Australian government funds $1M for development of Covax-19® vaccine (MTPConnect)
The pioneering team at Vaxine who developed the world’s first swine flu vaccine in 2009, has been awarded funding of $1 million dollars from the Biomedical Translation Bridge (BTB) program, an initiative of the Medical Research Future Fund operated by MTPConnect, to help advance Vaxine’s state-of-the-art COVID-19 vaccine candidate called Covax-19®.
Sharen Pringle, Vaxine’s Business Manager said the Vaxine team are very proud to be leading the Australian effort in development of COVID-19 vaccines.
Full link ot the article
5 thoughts on “Australian government funds $1M for development of Covax-19® vaccine (MTPConnect)”
Allan Kelly
September 12, 2020 at 03:32 PMThe Vaxine company has no registered presence on the Stock exchange so how can a investor support the efforts of Vaxine?
admin
November 16, 2020 at 12:02 AMHopefully we will list one day so that you can be part of this innovative company.
sikis izle
November 14, 2020 at 11:55 AMI truly appreciate this blog article. Really looking forward to read more. Keep writing. Mora Adair Portuna
sikis izle
November 14, 2020 at 09:26 PMI think this is a real great post. Much thanks again. Fantastic. Carol-Jean Branden Alessandra
erotik izle
November 15, 2020 at 10:57 PMHello. This article was extremely motivating, especially since I was looking for thoughts on this topic last Monday. Kacie Victor Thurman